Targeting DNA topoisomerase II in cancer chemotherapy
Тип публикации: Journal Article
Дата публикации: 2009-04-20
SCImago Q1
Tоп 10% SCImago
WOS Q1
БС1
SJR: 22.814
CiteScore: 103.8
Impact factor: 66.8
ISSN: 1474175X, 14741768
PubMed ID:
19377506
General Environmental Science
General Earth and Planetary Sciences
Краткое описание
Recent molecular studies have expanded the biological contexts in which topoisomerase II (TOP2) has crucial functions, including DNA replication, transcription and chromosome segregation. Although the biological functions of TOP2 are important for ensuring genomic integrity, the ability to interfere with TOP2 and generate enzyme-mediated DNA damage is an effective strategy for cancer chemotherapy. The molecular tools that have allowed an understanding of the biological functions of TOP2 are also being applied to understanding the details of drug action. These studies promise refined targeting of TOP2 as an effective anticancer strategy.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
10
20
30
40
50
60
|
|
|
bioRxiv
52 публикации, 3.35%
|
|
|
European Journal of Medicinal Chemistry
51 публикация, 3.29%
|
|
|
International Journal of Molecular Sciences
36 публикаций, 2.32%
|
|
|
Scientific Reports
32 публикации, 2.06%
|
|
|
PLoS ONE
30 публикаций, 1.94%
|
|
|
Nucleic Acids Research
30 публикаций, 1.94%
|
|
|
Molecules
25 публикаций, 1.61%
|
|
|
Nature Communications
23 публикации, 1.48%
|
|
|
Bioorganic Chemistry
22 публикации, 1.42%
|
|
|
Journal of Medicinal Chemistry
21 публикация, 1.35%
|
|
|
Biochemical Pharmacology
19 публикаций, 1.23%
|
|
|
DNA Repair
18 публикаций, 1.16%
|
|
|
Bioorganic and Medicinal Chemistry
17 публикаций, 1.1%
|
|
|
Bioorganic and Medicinal Chemistry Letters
17 публикаций, 1.1%
|
|
|
Cancers
16 публикаций, 1.03%
|
|
|
Journal of Biological Chemistry
16 публикаций, 1.03%
|
|
|
Oncotarget
14 публикаций, 0.9%
|
|
|
Journal of Molecular Structure
12 публикаций, 0.77%
|
|
|
Biochemistry
12 публикаций, 0.77%
|
|
|
International Journal of Biological Macromolecules
11 публикаций, 0.71%
|
|
|
Journal of Enzyme Inhibition and Medicinal Chemistry
11 публикаций, 0.71%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
11 публикаций, 0.71%
|
|
|
Chemical Research in Toxicology
10 публикаций, 0.65%
|
|
|
Molecular Pharmacology
9 публикаций, 0.58%
|
|
|
Marine Drugs
9 публикаций, 0.58%
|
|
|
Cell Death and Disease
9 публикаций, 0.58%
|
|
|
Biochemical and Biophysical Research Communications
9 публикаций, 0.58%
|
|
|
Cell Reports
9 публикаций, 0.58%
|
|
|
Current Medicinal Chemistry
8 публикаций, 0.52%
|
|
|
10
20
30
40
50
60
|
Издатели
|
50
100
150
200
250
300
350
400
450
|
|
|
Elsevier
414 публикаций, 26.71%
|
|
|
Springer Nature
236 публикаций, 15.23%
|
|
|
Wiley
135 публикаций, 8.71%
|
|
|
MDPI
133 публикации, 8.58%
|
|
|
American Chemical Society (ACS)
88 публикаций, 5.68%
|
|
|
Royal Society of Chemistry (RSC)
56 публикаций, 3.61%
|
|
|
openRxiv
52 публикации, 3.35%
|
|
|
Taylor & Francis
49 публикаций, 3.16%
|
|
|
Oxford University Press
45 публикаций, 2.9%
|
|
|
Public Library of Science (PLoS)
42 публикации, 2.71%
|
|
|
Bentham Science Publishers Ltd.
29 публикаций, 1.87%
|
|
|
Frontiers Media S.A.
23 публикации, 1.48%
|
|
|
American Association for Cancer Research (AACR)
21 публикация, 1.35%
|
|
|
Impact Journals
17 публикаций, 1.1%
|
|
|
American Society for Biochemistry and Molecular Biology
17 публикаций, 1.1%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
13 публикаций, 0.84%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
11 публикаций, 0.71%
|
|
|
SAGE
10 публикаций, 0.65%
|
|
|
American Association for the Advancement of Science (AAAS)
9 публикаций, 0.58%
|
|
|
Hindawi Limited
9 публикаций, 0.58%
|
|
|
Spandidos Publications
8 публикаций, 0.52%
|
|
|
American Society for Microbiology
8 публикаций, 0.52%
|
|
|
Portland Press
7 публикаций, 0.45%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
6 публикаций, 0.39%
|
|
|
Pleiades Publishing
5 публикаций, 0.32%
|
|
|
European Molecular Biology Organization
5 публикаций, 0.32%
|
|
|
Rockefeller University Press
5 публикаций, 0.32%
|
|
|
Georg Thieme Verlag KG
5 публикаций, 0.32%
|
|
|
IntechOpen
4 публикации, 0.26%
|
|
|
50
100
150
200
250
300
350
400
450
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
1.6k
Всего цитирований:
1553
Цитирований c 2025:
156
(10.07%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Nitiss J. L. Targeting DNA topoisomerase II in cancer chemotherapy // Nature Reviews Cancer. 2009. Vol. 9. No. 5. pp. 338-350.
ГОСТ со всеми авторами (до 50)
Скопировать
Nitiss J. L. Targeting DNA topoisomerase II in cancer chemotherapy // Nature Reviews Cancer. 2009. Vol. 9. No. 5. pp. 338-350.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1038/nrc2607
UR - https://doi.org/10.1038/nrc2607
TI - Targeting DNA topoisomerase II in cancer chemotherapy
T2 - Nature Reviews Cancer
AU - Nitiss, John L
PY - 2009
DA - 2009/04/20
PB - Springer Nature
SP - 338-350
IS - 5
VL - 9
PMID - 19377506
SN - 1474-175X
SN - 1474-1768
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2009_Nitiss,
author = {John L Nitiss},
title = {Targeting DNA topoisomerase II in cancer chemotherapy},
journal = {Nature Reviews Cancer},
year = {2009},
volume = {9},
publisher = {Springer Nature},
month = {apr},
url = {https://doi.org/10.1038/nrc2607},
number = {5},
pages = {338--350},
doi = {10.1038/nrc2607}
}
Цитировать
MLA
Скопировать
Nitiss, John L.. “Targeting DNA topoisomerase II in cancer chemotherapy.” Nature Reviews Cancer, vol. 9, no. 5, Apr. 2009, pp. 338-350. https://doi.org/10.1038/nrc2607.
Ошибка в публикации?